P&G Resources

Executive Summary – Earnings Report and Stock Reaction – January 2026

Business people

Executive summary

Procter & Gamble reported fiscal 2026 second quarter earnings on Thursday, January 22. Core EPS results were slightly ahead of consensus estimates ($1.88 vs. $1.86) while revenue fell short ($22.21Bn vs. $22.28Bn). Despite the mixed results, the stock closed at $149.93, up over +2.6% from the prior day close. Q2 organic sales growth was flat, with Beauty and Health Care segments registering +4% and +3% organic growth, respectively, and the Baby, Feminine & Family Care segment declining -4%. During the quarter, organic volume declined -1%, offset by +1% organic growth from pricing. In summary, the soft results were as expected, driven by market trends and base period dynamics. Management’s reaffirmation of full fiscal year guidance ranges for organic sales growth and core EPS seems to have provided investors a sense of relief if not optimism.

What we like

Excluding the negative impacts affecting the Baby, Feminine & Family Care segment and, to a lesser extent, the Fabric & Home Care segment, the rest of the Company grew organic sales nearly 3%, with almost all regions outside the U.S. growing or accelerating during the quarter.

Two segments, Beauty and Health Care, delivered solid growth in the quarter with organic sales up 4% and 3%, respectively. In a quarter where Company organic sales growth was flat, this highlights the dramatic drag effect from base period trade and consumer pantry-loading in the U.S. coupled with competitor promotional spending in the current quarter. Management has expressed confidence in a return to expected growth levels in the U.S. in the back half of the fiscal year.

We also note the continuation of robust growth in Greater China and Latin America. Greater China Q2 organic sales grew 3%, led by Pampers and SK-II (skin care), following 5% growth in Q1. Latin America Q2 organic sales grew 8%,
led by Mexico and Brazil, following 7% growth in Q1.

What bears watching

In the U.S., P&G’s largest market, data indicates increasing consumer trade-down in some of P&G’s key categories. North America Q2 organic sales were down -2% and volume down -3%. Management has highlighted soon-tolaunch innovation in the U.S., as well as the lapping of an abnormally difficult base period, as reasons for confidence in a return to expected growth levels. Uncertainty around the extent of the impacts, and when they will take hold, is a risk factor to monitor, especially given the persistence of the budget-stretched U.S. consumer on the low end of the K-shaped economy.

Bottom line

Fiscal 2026 Q2 was a challenging quarter for P&G, marked by flat organic sales overall and declines in North America. Management has clearly framed its expectation that Q2 will be the year’s weakest quarter, with stronger performance in the back half of the year on innovation driven improvement in the U.S. and continued strength internationally. Full year guidance ranges are maintained, forecasting 0-4% organic sales growth, and core EPS growth of 0-4%. P&G returned $4.8 billion to shareholders during the quarter, including $2.5 billion in dividends and $2.3 billion in share repurchases. Management guided to $15 billion of full year shareholder cash returns comprised of $10 billion in dividends and $5 billion in stock buybacks. Though the challenging quarter represents a clear bump in the road, management’s track record and commitment to its integrated growth strategy focused on reinvesting for superiority of its portfolio of daily-use categories, fueled by gains from faithful execution of productivity plans, is a reasonable basis to expect improved results and balanced growth for fiscal 2026.

Mariner and P&G are unaffiliated entities.

This material is provided for informational and educational purposes only. The information has been obtained from what we believe is a reliable source (P&G), but Mariner makes no warranties about the completeness, accuracy, or reliability of such information. Any opinions expressed herein are subject to change without notice. Nothing herein should construed as a individualized recommendation or personalized investment advice. Please consult with your advisor regarding your personal situation before making any financial or investment related decisions.

Investing involves risk and the potential to lose principal. Past performance is no guarantee of future results.

Please note that comments summarized herein based on the earnings call and include forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from any future results expressed or implied by the forward-looking statements. For more information on the factors that could influence results, including risks and uncertainties, please refer to P&G SEC filings.

Mariner is the marketing name for the financial services businesses of Mariner Wealth Advisors, LLC and its subsidiaries. Investment advisory services are provided through the brands Mariner Wealth, Mariner Independent, Mariner Institutional, Mariner Ultra, and Mariner Workplace, each of which is a business name of the registered investment advisory entities of Mariner. For additional information about each of the registered investment advisory entities of Mariner, including fees and services, please contact Mariner or refer to each entity’s Form ADV Part 2A, which is available on the Investment Adviser Public Disclosure website (www.adviserinfo.sec.gov). Registration of an investment adviser does not imply a certain level of skill or training.

Let’s talk about maximizing your relationship with Procter & Gamble.

Contact our dedicated Procter & Gamble wealth management team.

You May Also Like…